Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis

ŁJ Walczak-Nowicka, M Herbet - International journal of molecular …, 2021 - mdpi.com
Acetylcholinesterase (AChE) plays an important role in the pathogenesis of
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …

Diagnosis and treatment of orthostatic hypotension

W Wieling, H Kaufmann, VE Claydon… - The Lancet …, 2022 - thelancet.com
Orthostatic hypotension is an unusually large decrease in blood pressure on standing that
increases the risk of adverse outcomes even when asymptomatic. Improvements in …

Medical, surgical, and physical treatments for Parkinson's disease

T Foltynie, V Bruno, S Fox, AA Kühn, F Lindop, AJ Lees - The Lancet, 2024 - thelancet.com
Although dopamine replacement therapy remains a core component of Parkinson's disease
treatment, the onset of motor fluctuations and dyskinetic movements might require a range of …

Medicinal chemistry strategies for the development of Bruton's tyrosine kinase inhibitors against resistance

SL Sun, SH Wu, JB Kang, YY Ma, L Chen… - Journal of Medicinal …, 2022 - ACS Publications
Despite significant efficacy, one of the major limitations of small-molecule Bruton's tyrosine
kinase (BTK) agents is the presence of clinically acquired resistance, which remains a major …

Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases

H Khan, N Garg, TG Singh, A Kaur, K Thapa - Neurochemical Research, 2022 - Springer
It is considered a significant challenge to understand the neuronal cell death mechanisms
with a suitable cure for neurodegenerative disorders in the coming years. Calpains are one …

Novel benzothiazole sulfonamides as potent α-glucosidase and cholinesterase inhibitors: design, synthesis, structural properties, biological evaluation and docking …

S Khair-ul-Bariyah, M Sarfraz, A Sharif… - Journal of Molecular …, 2024 - Elsevier
A simplified synthetic method yielded diverse 2-aminobenzothiazole variants through
sulfonylation and amino group alkylation. Extensive characterization via X-ray diffraction …

Synthesis, structural properties and potent bioactivities supported by molecular docking and DFT studies of new hydrazones derived from 5-chloroisatin and 2 …

M Arshad, K Ahmed, M Bashir, N Kosar… - Journal of Molecular …, 2021 - Elsevier
New hydrazones were synthesized by employing a convergent synthetic methodology
involving condensation of N-alkyl 5-chloroisatins with hydrazone derived from 2 …

Clinical milestones in Parkinson's disease: Past, present, and future

L Marsili, A Mahajan - Journal of the Neurological Sciences, 2022 - Elsevier
Clinical disease milestones (literally a stone functioning as a milepost in ancient Rome; in
medical sciences, a significant event or stage in disease progression) are clinically relevant …

[HTML][HTML] An Update on Nondopaminergic Treatments for Motor and Non-motor symptoms of Parkinson's disease

XZ Jing, XZ Yuan, X Luo, SY Zhang… - Current …, 2023 - ncbi.nlm.nih.gov
Nondopaminergic neurotransmitters such as adenosine, norepinephrine, serotonin,
glutamate, and acetylcholine are all involved in Parkinson's disease (PD) and promote its …

Development of covalent inhibitors: Principle, design, and application in cancer

L Zheng, Y Li, D Wu, H Xiao, S Zheng… - MedComm …, 2023 - Wiley Online Library
Covalent inhibitors have been a rapidly growing field in drug discovery due to their
therapeutic potential and unique advantages in cancer therapy. As opposed to noncovalent …